Evidence map

ReviewBiomedicines2026

Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities.

Veronika A Prikhodko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42072449